Evidence map›Paper›PMID 42078418›Full record

ArticleOpen life sciences2026

Functionalized chitosan-graphene magnetic nanocomposites enhance collagen synthesis in scleral fibroblasts.

Xiaojie Huang, Zijian Wang, Min Zhang, Yingying Dai, Ruikang Tian

Abstract read
In one paragraph

Article in Open life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaojie HuangZhejiang Industry and Trade Vocational College, Wenzhou, Zhejiang, China.
Zijian WangWenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0009-0000-7094-5729
Min ZhangZhejiang Industry and Trade Vocational College, Wenzhou, Zhejiang, China.
Yingying DaiZhejiang Industry and Trade Vocational College, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0003-3005-2875
Ruikang TianZhejiang Industry and Trade Vocational College, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0009-0006-9772-7581

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the effects of magnetic stimulation mediated by magnetic/graphene (MNP/G) composite nanomaterials on human scleral fibroblast (HFSF) proliferation and collagen synthesis, exploring its potential for myopia prevention. MNP/G nanomaterials were synthesized via covalent co-precipitation and introduced into HFSF cultures. Cells were co-cultured with 30 μg/mL MNP/G and exposed to static magnetic stimulation (20 mT intensity). Proliferation was assessed via CCK-8 assay, morphology was observed using inverted phase-contrast microscopy, and hydroxyproline content was measured to quantify collagen synthesis. Magnetic stimulation significantly enhanced HFSF proliferation compared to non-stimulated controls, with no observed cytotoxicity. Microscopic analysis revealed improved cell density and spindle-like morphology in stimulated groups. Hydroxyproline assays demonstrated a marked increase in collagen synthesis following magnetic stimulation, suggesting enhanced extracellular matrix production. Notably, the combined application of MNP/G nanomaterials and magnetic stimulation yielded the highest collagen content among all experimental conditions. Magnetic stimulation using MNP/G nanomaterials promotes HFSF proliferation and collagen production, potentially strengthening scleral biomechanical properties. This approach may counteract scleral remodeling in myopia progression, offering a novel strategy for non-invasive myopia intervention.

Indexed as

magnetic stimulationmyopiascleral fibroblasts

Identifiers

PMID42078418
PMCPMC13134834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.